Here are four things to know:
1. Mr. France said the companies may very well decide their ASCs and ASC services may not compliment their physician services business lines following the merger, which may cause the combined entity to leave the ASC industry.
2. Mr. France wrote, “We estimate AMSG ambulatory surgical centers could be worth $2-$2.5 billion and EVHC’s AMR ambulance business $2.2-$2.8 billion. We think such a restructuring could translate into a $4-$5 upside potential in the stock price.”
3. During the first quarter of 2016, AmSurg net revenues for ambulatory services reached $307.1 million, up 8 percent from $283.9 million for the first quarter the year prior. The company’s net revenues reached $724.7 million, a 27 percent increase from $570.4 million for the same quarter of 2015.
4. However, William A. Sanger, Envision’s chairman of the board, president and CEO, did not delve into specific plans about divesting parts of their combined business. Mr. Sanger did, however, discuss the possibility of cross-selling the company’s services.
More articles on surgery centers:
AmSurg finalizes $10B merger with Envision Healthcare, SCA establishes its 1st physician advisory board & more — 6 key notes on ASC companies
SCA short interest up 4.21% — 5 notes
SCA establishes its 1st physician advisory board, with 6 members
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.